FDA Inspection 1165397 — Shirish M. Gadgeel, MD
The FDA completed an inspection of Shirish M. Gadgeel, MD on March 14, 2022 in Detroit, MI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 14, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Detroit, MI (United States)
Additional Details
Clinical Investigator (CI)